Gabather AB (publ) (STO:GABA)

Market Cap	7.75M
Revenue (ttm)	n/a
Net Income (ttm)	-4.75M
Shares Out	236.20M
EPS (ttm)	-0.04
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	2,575,642
Average Volume	2,288,125
Open	0.0294
Previous Close	0.0280
Day's Range	0.0282 - 0.0350
52-Week Range	0.0250 - 0.6980
Beta	-0.45
RSI	42.41
Earnings Date	Nov 27, 2025

About Gabather AB

Gabather AB (publ), a pharmaceutical company, develops drug candidates for the treatment of central nervous system diseases. The company offers drugs primarily in the areas of anti-psychotics, anti-depressants and anxiolytics, and analgesics, as well as cognition-enhancing treatments, including Alzheimer’s disease. It focuses on developing GT-002, a pro-cognitive drug candidate for the treatment of Alzheimer’s disease, schizophrenia, and major depressive disorders. The company was incorporated in 2014 and is based in Södertälje, Sweden.

• Industry: Drug Manufacturers - Specialty & Generic
• Sector: Healthcare
• Founded: 2014
• Employees: 3
• Stock Exchange: Nasdaq Stockholm
• Ticker Symbol: GABA